AJB Investment Fund II, LP (Bradley Adam James, Bradley Melinda Hodges) purchased $32K of JCTC (indirect holdings)

AJB Investment Fund II, LP purchased 10,897 indirectly-held shares of JEWETT CAMERON TRADING CO LTD (JCTC) at an average of $2.90 ($2.90–$2.92) across 4 trades over 2026-08-20 to 2026-08-21. Filed jointly with AJB Capital, LLC (10% owner), Bradley Adam James (10% owner) and Bradley Melinda Hodges (10% owner).

Original reporting
SEC EDGAR · AJB Investment Fund II, LP, AJB Capital, LLC, Bradley Adam James, Bradley Melinda Hodges
Published Aug 21, 2026, 11:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 22, 2026, 12:36 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$JCTC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The transaction represents a modest increase in insider ownership, unlikely to move the stock significantly.

02

Market read

Primary disclosure of a small insider purchase; limited trading relevance.

03

What to watch

Potential future insider activity or larger stake accumulation not evident from this single filing.

Relevance 4/10Novelty 4/10Timing: filing today

Background

SEC Form 4 filing discloses an insider purchase of 10,897 shares of Jewett Cameron Trading Co Ltd (JCTC) for $31,638.57.

Market effects

none

none

none

Counterpoint

The small purchase may be a routine portfolio adjustment with limited market impact.

Key entities

  • Jewett Cameron Trading Co Ltd

    Issuer of the shares purchased.

  • AJB Investment Fund II, LP

    Reporting entity and 10% owner.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).